
Axicabtagene Ciloleucel (Yescarta®)
Author(s) -
Adam Melaragno
Publication year - 2019
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000559656.58313.68
Subject(s) - medicine , chimeric antigen receptor , immunotherapy , cytokine release syndrome , antigen , t cell , immunology , cd28 , cd19 , cell therapy , oncology , cd8 , immune system , stem cell , biology , microbiology and biotechnology